Accrued Expenses and Other Liabilities (Tables)

12 Months Ended

Dec. 31, 2024

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following:

	As of December 31,
$s in thousands	2024		2023
Accrued interest expense	$	6,487	$	6,448
Contingent consideration	6,219		8,486
Deferred revenue	858		—
Accrued salaries, wages and bonuses	1,635		1,099
Deferred underwriting fee payable	1,500		1,500
Warrant liabilities	1,066		5,596
Accrued foreign tax	925		2,707
Finance right-of-use liability	37		46
Embedded derivative of Series A Preferred Stock	—		885
Accrued professional fees	—		851
Other	718		327
Total accrued expenses and other liabilities	19,445		27,945
Less: Current accrued expenses and other current liabilities	(14,057)		(17,168)
Total long-term accrued expenses and other noncurrent liabilities	$	5,388	$	10,777

Schedule of Contingent Consideration

The change in contingent consideration for the years ended December 31, 2024 and 2023 was as follows:

$s in thousands	2024		2023
Contingent consideration, beginning of period	$	8,486	$	—
Addition of contingent consideration from FMS Acquisition	2,164		—
Addition of contingent consideration from Ignis Acquisition	—		8,319
Change in fair value of contingent consideration	(393)		167
Settlement of contingent consideration	(4,038)		—
Contingent consideration, end of period	$	6,219	$	8,486